Back to search

Cornell University

Cellular Delivery of TRAIL to Treat Metastatic Castration-Resistant Prostate Cancer

Abstract

dc:description.abstract

Metastatic castration-resistant prostate cancer (mCRPC) is currently incurable. When diagnosed at early stages, prostate cancer is very treatable with surgery, radiation, and androgen deprivation (ADT) therapy. Within years, patient tumors will become resistant to ADT and eventually spread becoming metastatic. Current treatment options for mCRPC are available, but more as palliative care to increase the quality of life of these affected patients with minor improvement to overall survival. New therapeutic approaches are needed, to not only improve the survival of such patients, but to also find more aggressive therapy options for high risk populations that have higher tumor growth rates, larger tumor volumes, and higher mortality rates. Here, we present a therapeutic option that uses TNF-related apoptosis inducing ligand (TRAIL) on nanoscale liposomes, along with current FDA-approved chemotherapies, docetaxel and cabazitaxel, to treat models of mCRPC. Th scope of the work presented includes: (1) An investigation of the spatial density of leukocytes armed with TRAIL that infiltrate and treat primary prostate tumors, (2) an investigation of TRAIL-sensitization mechanisms in TRAIL-resistant cell lines using taxane therapy in 2D cell culture, and (3) an evaluation of overcoming TRAIL-resistance via taxane exposure using 3D spheroids.

Degree

thesis:*
Name thesis:degree_name
Ph. D., Biomedical Engineering
Level thesis:degree_level
Doctor of Philosophy
Discipline thesis:degree_discipline
Biomedical Engineering
Grantor
Cornell University
Year dc:date.issued
2020

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Grayson, Korie
Chair dc:contributor.chair
  • King, Michael
Committee members dc:contributor.committeemember
  • Putnam, David A.
  • Schaffer, Chris
  • Nishimura, Nozomi

Subjects

dc:subject × 6

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language.iso
en

Identifiers

dc:identifier.*
Dc Identifier Bibid
13277851
Dc Identifier Other
ProQuest Submission ID: 12058
ProQuest Publication ID: 28001089

Chain of custody

source
Harvested from
Cornell University
Base URL
ecommons.cornell.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Grayson, Korie. Cellular Delivery of TRAIL to Treat Metastatic Castration-Resistant Prostate Cancer. Doctor of Philosophy thesis, Cornell University, 2020. https://hdl.handle.net/1813/102872